Sharma and colleagues proposed the involvement of MeCP2 in glioma by showing that MeCP2 overexpression can inhibit proliferation, migration, invasion, and adhesion while inhibiting malignant behavior in glioma cells by inhibiting pERK and BDNF and inducing GFAP [136]. The gene discussed is BDNF; the disease is central nervous system cancer.